Dr. Paul D. Ullom-Minnich

Dr. Ullom-Minnich also performs colonoscopy procedures for colorectal screening and diagnosis.

Dr. Ullom-Minnich also performs upper GI endoscopy (EGD) procedures for acid reflux and digestive evaluation.

Dr. Ullom-Minnich also performs melanoma and skin cancer excision procedures.

Dr. Paul D. Ullom-Minnich provides patient consultations ranging from routine follow-ups to comprehensive evaluations, with follow-up visit being a key part of his practice. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 52% below the billed amount.

Dr. Paul D. Ullom-Minnich manages inpatient hospital care including admissions, daily rounds, critical care, and discharge coordination, including daily hospital rounds and nursing facility admission and hospital admission. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 54% below the billed amount.

Dr. Paul D. Ullom-Minnich delivers preventive health services including wellness visits, vaccinations, and health screenings, including flu vaccine and pneumonia vaccine and annual wellness visit; includes a personalized prevention plan of service , initial visit.

Dr. Paul D. Ullom-Minnich orders and interprets diagnostic tests to support clinical decision-making, including hemoglobin A1c test, urinalysis, and other related services. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 86% below the billed amount.

Dr. Paul D. Ullom-Minnich utilizes diagnostic imaging to evaluate and monitor patient conditions, with chest X-ray being a key part of his practice. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 78% below the billed amount.

Dr. Paul D. Ullom-Minnich provides dermatological care including skin evaluations and treatment, including destruction of precancer skin growth, 2-14 growths and skin lesion removal. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 64% below the billed amount.